
Adia Med surpasses Nasdaq's 300 round-lot shareholder minimum for potential uplisting.
Adia Med has verified it has 361 round-lot shareholders, exceeding Nasdaq Capital Market's minimum requirement of 300 for an initial listing. This milestone is part of Adia Med's ongoing efforts to meet Nasdaq's listing standards, though other criter...

